Press "Enter" to skip to content

New Drug-Resistant Fungal Infections Flare-up New Health Concerns

Public health experts are concerned about Fungal Infections cases caused by the fungus called Candida Auris in the U.S. The cases were reported in the country previously, but these new cases are concerning because of their resistance to existing drugs.

There have been cases where the Fungal Infections became resistant to drugs in patients who received treatment. The new cases were reported in the July 23 Morbidity and Mortality Weekly Report from the Centers for Disease Control and Prevention. Meghan Lyman, a medical officer in the mycotic diseases branch in CDC’s National Center for Emerging and Zoonotic Infectious Diseases, to STAT said that this is the first time that they have identified clusters of Fungal Infections with common health care exposures in the same facilities and among patients who had not received antifungals.

According to the MMWR, the new drug-resistant cases were reported in Washington, D.C., and Texas between January and April 2021. Three isolates in D.C. and two in Texas were pan-resistant, meaning it was resistant to all three categories of antifungal drugs. Five cases in Texas were resistant to two categories of drugs.The health experts at the institutions tested for C. Auris from skin samples of patients at health care facilities, including long-term care facilities.

Lyman says that they tend to see transmission and see cases among patients who are in these high-acuity, long-term care facilities. They have very high-acuity, very sick patients like ones who are on ventilators or have tracheostomy or other invasive medical devices. Getting Covid and then having these complications put them at higher risk for acquiring Candida Auris.Treatment options for C. Auris are limited, and drug resistance has been a growing issue. If this evidence is what it seems, that could mean that the fungus can spread, and patients may develop infections that are potentially untreatable.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *